NCT05431972View on ClinicalTrials.gov

Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement

NAUnknownINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2024

Conditions
Embolic Stroke of Undetermined Source
Interventions
DEVICE

Cardea SOLO

Neurologist cardiac rhythm translation with 12 lead EKG versus Cardea SOLO

DEVICE

12 Lead EKG

Neurologist cardiac rhythm translation with 12 lead EKG versus Cardea SOLO

Trial Locations (1)

Unknown

RECRUITING

BumJoon Kim, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT05431972 - Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement | Biotech Hunter | Biotech Hunter